Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Shanghai Xinhua Hospital stories

Jul 24, 2026

Investigation Reveals Unreported Child Death in China’s First Brain-Directed CRISPR Trial

A 6-year-old girl died after receiving experimental gene-editing therapy for a non-life-threatening neurodevelopmental condition in Shanghai, with her death kept secret until uncovered by an investigation by Science and Retraction Watch. The family reportedly paid over $800,000 for the treatment.

Jul 24, 2026·6 sources
00

Top claims

  • ▪Seven genetics, virology, and bioethics experts stated that the research team downplayed trial risks to the parents and overlooked safety signals in animal studies.
  • ▪Shanghai Xinhua Hospital was fined approximately $3,600 for its failures in the trial, and the overseeing physician, Yongguo Yu, received verbal counseling.
  • ▪The experimental therapy was designed to correct a genetic mutation affecting the six-year-old girl's neurodevelopment.

Topics

ChinaDrug Approval and Clinical Trials

Related entities

ShanghaiChina